Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move: TSXV: $TBP.V,
CSE: $GLH.C, OTCQB: $GSRX, TSXV: $ABCN.V, OTC: $ADYNF
August 3rd Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis
company with a new disruptive drug delivery platform: DehydraTECH
Delta, Kelowna, BC –August 3, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Read this in full at http://www.investorideas.com/news/2018/cannabis/08032Potcasts-TSXV-TBP-CSE-GLH-OTCQB-GSRX-ABCN-ADYNF.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features news from Tetra Bio-Pharma Inc. trading on the TSX-VENTURE as TBP and the
OTCQB as TBPMF, Golden Leaf Holdings
Ltd. trading on the CSE as GLH and the OTCQB as GLDFF, GSRX Industries
Inc. trading on the OTCQB as GSRX, ABcann
Global Corporation trading on the TSX-Venture as ABCN and OTCQB as ABCCF
and ALGAE DYNAMICS CORP trading on the OTC as ADYNF.
Tetra Bio-Pharma Inc., a leader in
cannabinoid-based drug discovery and development, today announced that the
company has provided an extension to North Bud Farms Inc. Tetra and North
Bud Farms Inc. are working diligently to finalize the transaction and to this
end Tetra Bio-Pharma has agreed to provide an extension to North Bud Farms Inc.
with regards to the final receipt of North Bud’s prospectus’. As one of
the closing conditions to the sale these documents must now be submitted by
August 31, 2018. Upon final receipt of North Bud’s prospectus and meeting
the requirements requested by the Ontario Securities Commission, Tetra will
announce the record date and begin the process with the distribution of the
dividend which must be finalized before listing the shares of North Bud Farms
Inc.
Golden Leaf Holdings Ltd., a cannabis company with
cultivation, production and retail operations built around recognized brands,
today announced its upcoming attendance at a number of major cannabis industry
and investor events.
From August 8 to 9, Golden Leaf CEO William Simpson will present at the Canaccord Genuity’s 38th Annual Growth
Conference taking place in Boston, Massachusetts. The Canaccord
conference is a premier investment forum for innovative small and mid-cap
growth companies from the U.S., Canada, and the U.K.
Later in the month, management will attend MJBIZCon Int’l in Toronto, Ontario from August 14 to 16 as well as
CEO William Simpson will also present at the Benzinga Cannabis Capital Conference from August 16 to 17 in Toronto.
Simpson said, “Attending industry conferences and events provides
extremely valuable insight into the health of the industry as a whole and the
strategies, products and innovations that will shape the months and years to
come. They are important opportunities to interact with potential investors,
media, and industry leaders and to discuss the most critical topics impacting
cannabis today.”
GSRX Industries Inc., through its wholly-owned subsidiary, Project 1493
LLC, announced today that it has received pre-qualification and preliminary
approval for a medicinal cannabis transportation license in Puerto Rico.
This is in addition to the eight dispensary pre-qualifications it has received
to date, as well as pre-qualification for a medicinal cannabis manufacturing
license recently received. Of its pre-qualified dispensary locations,
Green Spirit RX dispensaries are currently operating in Dorado, Carolina, and
San Juan (Hato Rey), with five locations in various stages of development and
construction in Fajardo, Isla Verde, San Juan (Andalucia), Bayamón, and Old San
Juan.
The pre-qualified transportation license allows GSRX to transport and
deliver cannabis between authorized dispensaries and patients’ homes in Puerto
Rico. Start of medicinal cannabis delivery by GSRX in Puerto Rico is
dependent upon numerous factors and will begin only after the pre-qualified
business undergoes requisite inspections and is issued all requisite permits
and licensing from the Puerto Rico Department of Health.
ABcann Global Corporation announced that, effective
immediately, it will be known as VIVO Cannabis Inc. — a contemporary
reflection of the Company’s evolution, purpose and direction. The name change
became effective at market open today and “VIVO” will replace “ABCN” as the
Company’s ticker symbol on the TSX Venture Exchange.
VIVO — which translates to “living” in Latin — embodies the Company’s
commitment to providing quality cannabis products and services that improve
lives. It’s the common thread that unites us all, and it’s the spirit behind
the rebranding. It also celebrates the recent announcement of the Company’s
proposed acquisition of Canna Farms Limited.
ALGAE DYNAMICS CORP , a company focused on the development of unique
health products and nutraceuticals utilizing cannabis and botanical oil
extracts, today announced it has received funding of CDN$520,000 through the
sale of $100,000 Canadian 10% Convertible Debentures (convertible into 400,000
shares of common stock at $0.25 CAN) and $420,000 CAN through the sale of
1,050,000 shares of restricted Common stock at $0.40 CAN and the issuance of
525,000 purchase warrants at $0.75 CAN via an Offering Memorandum from
accredited investors.
The Company intends to use the funds to further support Dr. Steven
Laviolette and his team at Western University and Dr. Jonathan Blay at The
University of Waterloo (announced previously).
Funds will also be allocated for patent applications, supporting
development activities with their Licensed Partners, general administrative
expenses and compliance.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, iHeartradio and
Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
No comments:
Post a Comment